+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brain Tumor Chemotherapy"

Brain Tumor Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Brain Tumor Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 161 Pages
  • Global
From
Neurology Market: A Research Overview - Product Thumbnail Image

Neurology Market: A Research Overview

  • Report
  • July 2019
  • 194 Pages
  • Global
From
Handbook of Brain Tumor Chemotherapy - Product Thumbnail Image

Handbook of Brain Tumor Chemotherapy

  • Book
  • December 2005
  • 4 Results (Page 1 of 1)
Loading Indicator

Brain tumor chemotherapy is a form of treatment for brain cancer that uses drugs to kill cancer cells. It is often used in combination with other treatments such as surgery and radiation therapy. The drugs used in brain tumor chemotherapy are typically administered intravenously or orally. The drugs work by targeting the cancer cells and preventing them from growing and dividing. The brain tumor chemotherapy market is a rapidly growing segment of the brain cancer drugs market. It is driven by the increasing prevalence of brain cancer, the development of new drugs, and the increasing availability of personalized treatments. The market is expected to continue to grow in the coming years as new treatments are developed and more patients are diagnosed with brain cancer. Some of the major companies in the brain tumor chemotherapy market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Show Less Read more